Co-Founder of Life Biosciences, Executive Chairman at Proto Axiom
Tristan Edwards is an investment professional and Co-founder, President and Chief Investment Officer of Life Biosciences. This US biotech start-up is researching potential treatments to improve human healthspan.
Tristan Edwards is Proto Axiom's Executive Chairman. Tristan has had a 25–year career, highlighted by co-founding and first CEO of Boston-based Life Biosciences, the world’s leading human longevity company, making drugs to treat causes of aging.
He previously spent 18 years global funds management experience spanning Australia, London, Hong Kong, and Singapore, trading all asset classes with a focus on Asian equities (Goldman Sachs Asset Management, Brevan Howard Asset Management, Trafalgar Capital, Mosaic Asset Management).
Visit website: https://www.protoaxiom.com/tristanedwards
See also: Life Biosciences - Drug development company promoting longevity and finding treatments for age-related diseases
Tristan Edwards News
Investing in the Longevity industry
Longevity Technology - 18-Sep-2019
Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseasesRead more...